As of Apr 29
| +0.03 / +1.30%|
The 3 analysts offering 12-month price forecasts for Solazyme Inc have a median target of 2.75, with a high estimate of 5.00 and a low estimate of 2.25. The median estimate represents a +17.52% increase from the last price of 2.34.
The current consensus among 3 polled investment analysts is to Hold stock in Solazyme Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.